Perspectives of people living with HIV and health workers about a point-of-care adherence assay: a qualitative study on acceptability

References

• Bardon, A. R., Simoni, J. M., Layman, L. M., Stekler, J. D., & Drain, P. K. (2020). Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: An exploratory qualitative assessment among U.S. clients and providers. AIDS Research and Therapy, 17(1), 1–10. https://doi.org/10.1186/s12981-020-00308-w
   PubMed Web of Science ®Google Scholar
• Campbell, J. I., Musiimenta, A., Burns, B., Natukunda, S., Musinguzi, N., Haberer, J. E., & Eyal, N. (2019). The importance of how research participants think they are perceived: Results from an electronic monitoring study of antiretroviral therapy in Uganda. AIDS Care, 31(6), 761–766. https://doi.org/10.1080/09540121.2018.1556381
   PubMed Web of Science ®Google Scholar
• Castillo-Mancilla, J. R., Zheng, J. H., Rower, J. E., Meditz, A., Gardner, E. M., Predhomme, J., Fernandez, C., Langness, J., Kiser, J. J., Bushman, L. R., & Anderson, P. L. (2013). Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Research and Human Retroviruses, 29(2), 384–390. https://doi.org/10.1089/aid.2012.0089
   PubMed Web of Science ®Google Scholar
• Drain, P., Ngure, K., Mugo, N., Spinelli, M., Chatterjee, P., Bacchetti, P., Glidden, D., Baeten, J., & Gandhi, M. (2020). Testing a real-time tenofovir urine adherence assay for monitoring and providing feedback to preexposure prophylaxis in Kenya (PUMA): Protocol for a pilot randomized controlled trial. JMIR Research Protocols, 9(4), e15029. https://doi.org/10.2196/15029
   PubMed Web of Science ®Google Scholar
• Gandhi, M., Bacchetti, P., Ofokotun, I., Jin, C., Ribaudo, H. J., Haas, D. W., Sheth, A. N., Horng, H., Phung, N., Kuncze, K., Okochi, H., Landovitz, R. J., Lennox, J., & Currier, J. S. (2019). Antiretroviral concentrations in hair strongly predict virologic response in a large human immunodeficiency virus treatment-naive clinical trial. Clinical Infectious Diseases, 68(6), 1044–1047. https://doi.org/10.1093/cid/ciy764
   PubMed Web of Science ®Google Scholar
• Gandhi, M., Bacchetti, P., Rodrigues, W. C., Spinelli, M., Koss, C. A., Drain, P. K., Baeten, J. M., Mugo, N. R., Ngure, K., Benet, L. Z., Okochi, H., Wang, G., & Vincent, M. (2018). Development and validation of an immunoassay for tenofovir in urine as a real-time metric of antiretroviral adherence. EClinicalMedicine, 2-3, 22–28. https://doi.org/10.1016/j.eclinm.2018.08.004
   PubMedGoogle Scholar
• Gandhi, M., Wang, G., King, R., Rodrigues, W. C., Vincent, M., Glidden, D. v., Cressey, T. R., Bacchetti, P., Spinelli, M. A., Okochi, H., Siriprakaisil, O., Klinbuayaem, V., Mugo, N. R., Ngure, K., Drain, P. K., & Baeten, J. M. (2020). Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings. Aids (london, England), 34(2), 255–260. https://doi.org/10.1097/QAD.0000000000002395
   PubMed Web of Science ®Google Scholar
• Haberer, J. E., Sabin, L., Amico, K. R., Orrell, C., Galárraga, O., Tsai, A. C., Vreeman, R. C., Wilson, I., Sam-Agudu, N. A., Blaschke, T. F., Vrijens, B., Mellins, C. A., Remien, R. H., Weiser, S. D., Lowenthal, E., Stirratt, M. J., Sow, P. S., Thomas, B., Ford, N., … Bangsberg, D. R. (2017). Improving antiretroviral therapy adherence in resource-limited settings at scale: A discussion of interventions and recommendations. Journal of the International AIDS Society, 20(1), 1–15. https://doi.org/10.7448/IAS.20.1.21371
   Google Scholar
• Herzer, M., Ramey, C., Rohan, J., & Cortina, S. (2012). Incorporating electronic monitoring feedback into clinical care: A novel and promising adherence promotion approach. Clinical Child Psychology and Psychiatry, 17(4), 505–518. https://doi.org/10.1177/1359104511421103
   PubMed Web of Science ®Google Scholar
• Huerga, H., Shiferie, F., Grebe, E., Giuliani, R., Farhat, J. B., Van-Cutsem, G., & Cohen, K. (2017). A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa. BMC Infectious Diseases, 17(1), 1–8. https://doi.org/10.1186/s12879-017-2740-y
   PubMedGoogle Scholar
• Hunt, T., Lalley-Chareczko, L., Daughtridge, G., Swyryn, M., & Koenig, H. (2019). Challenges to PrEP use and perceptions of urine tenofovir adherence monitoring reported by individuals on PrEP. AIDS Care of Psychological and Social-Medical Aspects of HIV/AIDS, 31(10), 1203–1206. https://doi.org/10.1080/09540121.2019.1587369
   PubMed Web of Science ®Google Scholar
• Kaplan, R., Orrell, C., Lawn, S. D., Bekker, L.-G., & Wood, R. (2014). The Hannan Crusaid Treatment Centre – early beginnings and lessons learnt. Southern African Journal of HIV Medicine, 15(1), 35. https://doi.org/10.7196/sajhivmed.1040
   Web of Science ®Google Scholar
• Meyer-Rath, G., Johnson, L. F., Pillay, Y., Blecher, M., Brennan, A. T., Long, L., Moultrie, H., Sanne, I., Fox, M. P., & Rosen, S. (2017). Changing the South African national antiretroviral therapy guidelines: The role of cost modelling. PLoS ONE, 12(10), 1–15. https://doi.org/10.1371/journal.pone.0186557
   Web of Science ®Google Scholar
• Moosa, A., Gengiah, T. N., Lewis, L., & Naidoo, K. (2019). Long-term adherence to antiretroviral therapy in a South African adult patient cohort: A retrospective study. BMC Infectious Diseases, 19(1), 775. https://doi.org/10.1186/s12879-019-4410-8
   PubMed Web of Science ®Google Scholar
• Nathan Georgette, M. J., & Siedner, B. Z. (2017). The acceptability and perceived usefulness of weekly SMS to promote HIV antiretroviral medication adherence in KwaZulu-Natal. AIDS and Behavior, 20(11), 2629–2638. https://doi.org/10.1007/s10461-016-1287-z.The
   Web of Science ®Google Scholar
• National Department of Health of South Africa. (2019). 2019 ART clinical guidelines for the management of HIV in adults, pregnancy, adolescents, children, infants and neonates.Updated March 2020.
   Google Scholar
• Phillips, T. K., Sinxadi, P., Abrams, E. J., Zerbe, A., Orrell, C., Hu, N. C., Brittain, K., Gomba, Y., Norman, J., Wiesner, L., Myer, L., & Maartens, G. (2019). A comparison of plasma Efavirenz and Tenofovir, dried blood spot tenofovir-diphosphate, and self-reported adherence to predict virologic suppression among South African Women. JAIDS Journal of Acquired Immune Deficiency Syndromes, 81(3), 311–318. https://doi.org/10.1097/QAI.0000000000002032
   PubMed Web of Science ®Google Scholar
• Proctor, E., Silmere, H., Raghavan, R., Hovmand, P., Aarons, G., Bunger, A., Griffey, R., & Hensley, M. (2011). Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda. Administration and Policy in Mental Health and Mental Health Services Research, 38(2), 65–76. https://doi.org/10.1007/s10488-010-0319-7
   PubMed Web of Science ®Google Scholar
• Rutakumwa, R., Mugisha, J. O., Bernays, S., Kabunga, E., Tumwekwase, G., Mbonye, M., & Seeley, J. (2020). Conducting in-depth interviews with and without voice recorders: A comparative analysis. Qualitative Research, 20(5), 565–581. https://doi.org/10.1177/1468794119884806
   PubMed Web of Science ®Google Scholar
• Spinelli, M. A., Glidden, D. V., Rodrigues, W. C., Wang, G., Vincent, M., Okochi, H., Kuncze, K., Mehrotra, M., Defechereux, P., Buchbinder, S. P., Grant, R. M., & Gandhi, M. (2019). Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project. Aids (london, England), 33(5), 867–872. https://doi.org/10.1097/QAD.0000000000002135
   PubMed Web of Science ®Google Scholar
• Spinelli, M. A., Rodrigues, W. C., Wang, G., Vincent, M., Glidden, D. v., Okochi, H., Stalter, R., Defechereux, P., Deutsch, M., Grant, R. M., Ngure, K., Mugo, N. R., Baeten, J. M., & Gandhi, M. (2020). Brief report: High accuracy of a real-time urine antibody-based tenofovir point-of-care test compared with laboratory-based ELISA in diverse populations. JAIDS Journal of Acquired Immune Deficiency Syndromes, 84(2), 149–152. https://doi.org/10.1097/QAI.0000000000002322
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2021). UNAIDS data 2021. https://www.unaids.org/en/resources/documents/2021/2021_unaids_data#:~:text=The%2090%E2%80%9390%E2%80%9390%20targets,on%20treatment%20were%20virally%20suppressed
   Google Scholar
• UNAIDS. UNAIDS data 2020. (2020). https://www.unaids.org/en/resources/documents/2020/unaids-data.
   Google Scholar